Form 4: Relay Therapeutics Executive Sells Shares to Cover Tax Obligations

Donald A. Bergstrom, President of R&D at Relay Therapeutics, sold 648 shares of common stock to cover income tax withholding obligations upon the vesting of restricted stock units.

Summary

• On June 27, 2024, Donald A. Bergstrom, President of R&D at Relay Therapeutics, sold 648 shares of Relay Therapeutics common stock.
• The sale was executed at a price of $6.26 per share.
• The transaction was conducted to cover income tax withholding obligations related to the vesting of 2,187 restricted stock units (RSUs) on June 26, 2024.
• Following the transaction, Bergstrom beneficially owns 526,779 shares of Relay Therapeutics common stock, including 470,309 shares underlying RSUs.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations and doesn't indicate any significant positive or negative development for the company.

Industry Context

Executive stock sales are a common occurrence, particularly around vesting events. This sale appears to be related to tax obligations and doesn't necessarily indicate a change in the executive's long-term outlook for the company.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant effect given the context of tax obligations.

Key Dates